«Vector-BiAlgam» — is one of the first enterprises of the scientific center, which managed to direct fundamental knowledge, applied scientific research, as well as innovative developments to the practical plane, namely, to the production of immunobiological products and probiotic-containing drugs designed to preserve and restore the health of the nation»

Nikulin Leonid G

«Vector-BiAlgam» JSC — is a biotechnology company specializing in the production of pharmaceutical immunobiological preparations and probiotic products

The main directions of the enterprise

  • Manufacture of vaccine against hepatitis A ALGAVAK® M;
  • Production of probiotic products;
  • Contract manufacturing of injectable pharmaceuticals;
  • Development and contract manufacturing of probiotics (liquid, powder, capsule forms).

The enterprise was founded in 1996 on the basis of the State Scientific Center for Virology and Biotechnology «Vector» in the science city of Koltsovo, which is an innovative territorial cluster of biopharmaceutical technologies in the Novosibirsk region.

«Vector-BiAlgam» is the only Russian manufacturer of a vaccine for the prevention of hepatitis A, which is not inferior in effectiveness to the world's leading analogues.

As part of the probiotic direction, our scientists create modern microbiological compositions that are highly effective and safe. Developments are used in medicine, food and cosmetic industries.

The enterprise has a high-tech production base, as well as a staff of experienced specialists, which ensures a high level of development and proper product quality. The production has GMP and HACCP certificates.